A Guide to Pharmacies in China: What Medicines Can Foreign Visitors Find?

A practical overview of pharmacy types in China, the medicines and healthcare supplies foreign visitors can find, and what to check before buying or carrying medicines abroad.

Top Stories

Ropeginterferon Alfa-2b, a Major Hematology Drug, Expands Its Indications: Essential Thrombocythemia

Understanding the Global Pharmaceutical Supply Chain: How Medicines Cross Markets and Borders

Latest Coverage

Zongertinib vs. Sevabertinib: Two Major Breakthroughs in HER2-Mutant Lung Cancer Treatment — What Are the Key Differences?
Beginning in 2025, zongertinib became the first oral targeted therapy approved worldwide for HER2-mutant NSCLC. Sevab...

From Intravenous Infusion to Oral Administration: Paclitaxel Oral Solution Gains a New Indication for Breast Cancer
In October 2026, a new development in the formulation of anticancer medicines emerged in China. On October 8, paclita...

KRAS Mutations and Precision Oncology: From KRAS G12C Inhibitors to Next-Generation RAS-Targeted Therapies
One of the key goals of precision oncology is to identify more targeted treatment strategies based on the molecular c...

Global First-in-Class Drug Approved in China: Vosoritide Brings Disease-Modifying Treatment to Children with Achondroplasia
On September 18, 2026, the official website of China’s National Medical Products Administration (NMPA) announced that...

Complete Guide to Lung Cancer Treatment in China: Costs, Leading Hospitals, and What International Patients Should Know
Lung cancer is one of the most common cancers and a leading cause of cancer-related deaths worldwide. China records m...

Atopic Dermatitis Welcomes an Important New Treatment: China Approves Ruxolitinib Phosphate Cream for Children Aged 2 and Older and Adults
For patients living with atopic dermatitis (AD), the burden of the disease goes beyond redness, dry skin, and rashes....

In-Depth Analysis

A Guide to Pharmacies in China: What Medicines Can Foreign Visitors Find?

Ropeginterferon Alfa-2b, a Major Hematology Drug, Expands Its Indications: Essential Thrombocythemia

Understanding the Global Pharmaceutical Supply Chain: How Medicines Cross Markets and Borders

Zongertinib vs. Sevabertinib: Two Major Breakthroughs in HER2-Mutant Lung Cancer Treatment — What Are the Key Differences?